当前位置: 首页 >> 检索结果
共有 60285 条符合本次的查询结果, 用时 3.8492279 秒

141. The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.

作者: Naveed Sattar.;Govinda J Weerakkody.;Darren K McGuire.;Mikhail N Kosiborod.;Matthew M Y Lee.;Paul Welsh.;Ewan R Pearson.;Russell J Wiese.;Kevin Duffin.;Jonathan Wilson.;Noemi Pavo.;Martin Hülsmann.;Imre Pavo.
来源: Circulation. 2025年151卷19期1430-1432页

142. Pressure-Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels.

作者: Ozan M Demir.;Aish Sinha.;Haseeb Rahman.;Matthew Ryan.;Kevin O'Gallagher.;Howard Ellis.;Matthew Li Kam Wa.;Smriti Saraf.;Khaled Alfakih.;Ian Webb.;Narbeh Melikian.;Kalpa De Silva.;Amedeo Chiribiri.;Sven Plein.;Divaka Perera.
来源: Circ Cardiovasc Interv. 2025年e015320页
Pressure-based physiological evaluation of coronary artery disease is well established, but its application is limited in left main coronary artery (LMCA) disease. Our aim was to investigate whether pressure-based indices are comparable in the left anterior descending (LAD) and left circumflex artery (LCx) branches of the LMCA, and if discordance is due to differences in microvascular function in these territories.

143. Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead.

作者: Amber B Tang.;Sabra C Lewsey.;Clyde W Yancy.;Paul A Heidenreich.;Stephen J Greene.;Larry A Allen.;Mariell Jessup.;Michele Bolles.;Christine Rutan.;Natalie Navar.;Kathie Thomas.;Gregg C Fonarow.
来源: Circ Heart Fail. 2025年e012936页
The Get With the Guidelines-Heart Failure program was developed in 2005 with the goal of bringing evidence-based guidelines in heart failure management into widespread clinical practice. The program includes workshops, webinars, tool kits, chart abstraction, performance benchmarking, and achievement awards to drive quality improvement at participating hospitals. Two decades after its inception, the program has grown to include over 600 participating institutions across the United States. Linking registry data to Centers for Medicare and Medicaid Services claims has also allowed for the evaluation of longitudinal outcomes. Get With the Guidelines-Heart Failure has helped improve the quality of care for patients and has contributed substantially to the understanding of clinical science and optimal management of heart failure. This narrative review provides an overview of the indelible impact of the Get With the Guidelines-Heart Failure program on quality heart failure care over the past 20 years and highlights future challenges and directions.

144. Stent-Edge Hinge Movement in a Calcified Lesion Is Associated With Increased Prevalence of a Calcified Nodule at Follow-Up.

作者: Yoichiro Sugizaki.;Mitsuaki Matsumura.;Yu-Wei Chen.;Takunori Tsukui.;Takehiko Kido.;Evan Shlofmitz.;Doosup Shin.;Koshiro Sakai.;Ali Dakroub.;Matthew J Granville.;Genie M Miraglia.;Kaylee Bressler.;Charles Tarantino.;Justin C Magee.;Jeffrey W Moses.;Omar K Khalique.;David J Cohen.;Gary S Mintz.;Richard A Shlofmitz.;Allen Jeremias.;Ziad A Ali.;Akiko Maehara.
来源: Circ Cardiovasc Interv. 2025年e015028页
Coronary stenting alters vessel dynamics, displacing hinge movement closer to stent edges. We aimed to investigate whether calcified nodules (CNs) are more frequent at stent edges associated with calcium.

145. Impact of Post-PCI Lipid Core Burden Index on Angiographic and Clinical Outcomes: Insights From NIRS-IVUS.

作者: Woohyeun Kim.;Hyungdon Kook.;Soojung Park.;Ran Heo.;Jin-Kyu Park.;Jinho Shin.;Yonggu Lee.;Young-Hyo Lim.
来源: Circ Cardiovasc Imaging. 2025年18卷6期e017740页
The impact of lipid core burden index (LCBI) after percutaneous coronary intervention (PCI) in the stented segment assessed by intracoronary near-infrared spectroscopy on the outcomes remains unclear.

146. Characterization of Aortic Valve Stenosis by CT Angiography in a Diverse US Cohort.

作者: Daniel Lorenzatti.;Annalisa Filtz.;Pamela Pina.;Jolien Geers.;Jake Gilman.;Jonathan Daich.;Paul Ippolito.;Abdullah Aftab.;Aldo L Schenone.;Carlos A Gongora.;Justin Johannesen.;Andrea Scotti.;Edwin C Ho.;Mario J Garcia.;Azeem Latib.;Carlos J Rodriguez.;Daniel S Berman.;Marie-Annick Clavel.;Philippe Pibarot.;Robert O Bonow.;Piotr J Slomka.;Marc R Dweck.;Damini Dey.;Leandro Slipczuk.
来源: Circ Cardiovasc Imaging. 2025年18卷6期e017858页
Aortic stenosis (AS) involves calcific and fibrotic degeneration of the valve tissue. The only noninvasive method for evaluating both processes is contrast-enhanced computed tomography angiography. We aimed to explore the differences in aortic valve (AV) tissue composition across sex, race/ethnicity, and AS hemodynamic phenotype in US patients referred for transcatheter AV replacement planning.

147. Letter by Shah Regarding Article, "Patent Foramen Ovale Closure in Patients With and Without Nickel Hypersensitivity: A Randomized Trial".

作者: Ashish H Shah.
来源: Circ Cardiovasc Interv. 2025年18卷6期e015497页

148. Data Interoperability and Harmonization in Cardiovascular Genomic and Precision Medicine.

作者: C Anwar A Chahal.;Fares Alahdab.;Babken Asatryan.;Daniel Addison.;Nay Aung.;Mina K Chung.;Spiros Denaxas.;Jessilyn Dunn.;Jennifer L Hall.;Nathalie Pamir.;David J Slotwiner.;Jose D Vargas.;Antonis A Armoundas.
来源: Circ Genom Precis Med. 2025年18卷3期e004624页
Despite advances in cardiovascular care and improved outcomes, fragmented healthcare systems, nonequitable access to health care, and nonuniform and unbiased collection and access to healthcare data have exacerbated disparities in healthcare provision and further delayed the technological-enabled implementation of precision medicine. Precision medicine relies on a foundation of accurate and valid omics and phenomics that can be harnessed at scale from electronic health records. Big data approaches in noncardiovascular healthcare domains have helped improve efficiency and expedite the development of novel therapeutics; therefore, applying such an approach to cardiovascular precision medicine is an opportunity to further advance the field. Several endeavors, including the American Heart Association Precision Medicine platform and public-private partnerships (such as BigData@Heart in Europe), as well as cloud-based platforms, such as Terra used for the National Institutes of Health All of Us, are attempting to temporally and ontologically harmonize data. This state-of-the-art review summarizes best practices used in cardiovascular genomic and precision medicine and provides recommendations for systems' requirements that could enhance and accelerate the integration of these platforms.

149. Developments in Digital Wearable in Heart Failure and the Rationale for the Design of TRUE-HF (Ted Rogers Understanding of Exacerbations in Heart Failure) Apple CPET Study.

作者: Yasbanoo Moayedi.;Farid Foroutan.;Yuan Gao.;Ben Kim.;Enza De Luca.;Margaret Brum.;Darshan H Brahmbhatt.;Joe Duhamel.;Anne Simard.;Christopher McIntosh.;Heather J Ross.
来源: Circ Heart Fail. 2025年18卷6期e012204页
Heart failure (HF) is a highly prevalent condition characterized by exercise intolerance, an important metric for ambulatory prognostication. However, current methods to assess exercise capacity are often limited to tertiary HF centers, lacking scalability or accessibility. Wearable devices can enable near-continuous dynamic biometrics including exercise tolerance.

150. Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

作者: Constantin-Cristian Topriceanu.;Christoffer Rasmus Vissing.;Anna Axelsson Raja.;Sharlene M Day.;Mark W Russell.;Kenneth Zahka.;Alexandre C Pereira.;Steven D Colan.;Anne M Murphy.;Charles Canter.;Richard G Bach.;Matthew T Wheeler.;Joseph W Rossano.;Anjali T Owens.;Luisa Mestroni.;Matthew R G Taylor.;James C Moon.;Gabriella Captur.;Amit R Patel.;Ivan Wilmot.;Jonathan H Soslow.;Jason R Becker.;Christine E Seidman.;Neal K Lakdawala.;Henning Bundgaard.;Usman A Tahir.;Carolyn Y Ho.
来源: Circ Heart Fail. 2025年18卷6期e012393页
In hypertrophic cardiomyopathy (HCM), the mechanisms through which pathogenic sarcomere variants (G+) lead to left ventricular hypertrophy (LVH) are not understood.

151. Response to Letter Regarding Article, "Abnormal Exercise Electrocardiography With Normal Stress Echocardiography Is Associated With Subclinical Coronary Atherosclerosis".

作者: Jessica M Duran.;Melissa A Daubert.
来源: Circ Cardiovasc Imaging. 2025年18卷6期e018367页

152. Novel Fibrosis Pattern in an Arrhythmogenic Cardiomyopathy Caused by a Titin-Truncating Variant.

作者: Melissa A Austin.;Tarryn Tertulien.;Bruk Mekonen.;Mahesh K Vidula.;Nosheen Reza.
来源: Circ Cardiovasc Imaging. 2025年e018149页

153. Interrupted Inferior Vena Cava, Partial Anomalous Pulmonary Venous Return and Extra-Mediastinal Superior Vena Cava: A Rare Case of Multilevel Congenital Anomalous Venous Return.

作者: Francisco Javier Ruperti-Repilado.;Gorka Gómez Ciriz.;Begoña Manso-García.
来源: Circ Cardiovasc Imaging. 2025年e017917页

154. Doughnut Sign: A Mixed Plaque Phenotype Unraveled Only by the Photon Counting CCTA.

作者: Pruthvi C Revaiah.;Patrick W Serruys.;Sean O Hynes.;Christos V Bourantas.;Helle Precht.;Yoshinobu Onuma.;Erica Maffei.;Filippo Cademartiri.
来源: Circ Cardiovasc Imaging. 2025年e017925页

155. Letter by Barbieri et al Regarding Article, "Abnormal Exercise Electrocardiography With Normal Stress Echocardiography Is Associated With Subclinical Coronary Atherosclerosis".

作者: Andrea Barbieri.;Francesca Bursi.;Francesca Mantovani.
来源: Circ Cardiovasc Imaging. 2025年18卷6期e018294页

156. Letter by Skalidis et al Regarding Article, "Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study)".

作者: Ioannis Skalidis.;Thomas Hovasse.;Philippe Garot.
来源: Circ Cardiovasc Interv. 2025年e015465页

157. From Pixels to Patterns: Radiomic Subphenotyping of Left Ventricular Hypertrophy on Echocardiography.

作者: Evangelos K Oikonomou.;Rohan Khera.
来源: Circ Cardiovasc Imaging. 2025年18卷5期e018291页

158. Toward Multiparametric MRI to Unravel Myocardial Pathology in Cardiac Amyloidosis.

作者: Olivier F Clerc.;Michael Jerosch-Herold.;Sharmila Dorbala.
来源: Circ Cardiovasc Imaging. 2025年18卷5期e018178页

159. Musclin and HFpEF: Unlocking Skeletal Muscle Potential to Improve Exercise Tolerance.

作者: Stephen J Foulkes.;Michael D Nelson.;Mark J Haykowsky.
来源: Circ Heart Fail. 2025年18卷6期e013130页

160. Unraveling the Rhythm: Sex-Based Molecular Signatures of Sinus Node Function and Arrhythmia Susceptibility.

作者: Takashi Ikenouchi.;Thassio Mesquita.;Eugenio Cingolani.
来源: Circ Arrhythm Electrophysiol. 2025年18卷5期e013981页
共有 60285 条符合本次的查询结果, 用时 3.8492279 秒